DHSC: OHID: Human Papillomavirus (HPV) Screening In Vaccinated Populations
Estimated value
£279k
Awarded value
£279k
Suppliers
1
Lots
1
Published
17 Apr 2023
Description
Provision of services to develop a cost-effective model to determine whether cervical cancer screening is clinically and cost effective in vaccinated populations in the UK. This model will project and compare the health benefits, harms, and costs associated with a range of strategies for HPV screening in vaccinated populations. Contract Project Reference: C162381 Contract term: 18 months with the option to extend for up to further 12 months Estimated contract value (including extensions): £278,990.00 (excluding of VAT); £334,788 (including VAT)
Scope
- Reference
- CF-1496100D0O000000rwimUAA
- Total value
- £278,990 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 16 Apr 2023 to 15 Oct 2024
- CPV classifications
- 73200000 73110000
Submission & procedure
- Submission deadline
- 10 Apr 2023, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£279k
Award date
13 Apr 2023
Contract start
16 Apr 2023
Contract end
15 Oct 2024